Showing results (1011-1020 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 6, 1993
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infectionG de Lissovoy, A Elixhauser, B R Luce, et al.Pharmacoeconomics|August 6, 1993
Drug expenditure and new drug introductions: the Swedish experienceU G Gerdtham, M Johannesson, B JönssonPharmacoeconomics|December 10, 1991
Comparative potency and dissolution performance of internationally available piroxicam productsJ A BaronePharmacoeconomics|January 9, 1992
Quality of life instruments in the evaluation of new drugsR Jaeschke, G H Guyatt, D CookPharmacoeconomics|February 7, 1993
Methods of minimising the cost of aminoglycoside therapy to hospitalsC A Gentry, K A Rodvold, J S BertinoPharmacoeconomics|July 7, 1992
Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's diseaseH M Bryson, R J Milne, P ChrispPharmacoeconomics|July 7, 1992
Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?D Coyle, K TolleyPharmacoeconomics|January 8, 1993
Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs)H A Wynne, M CampbellPharmacoeconomics|January 8, 1993
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugsL B Barradell, R Whittington, P BenfieldPharmacoeconomics|June 7, 1993
Test of an instrument to measure function-related quality of life in patients with ulcerative colitisA Zbrozek, R Hoop, M Robinson, et al.Pageof 336